Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | PRKDC | P78527 | 2/20 | 0.32 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | PPARD | Q03181 | 1/20 | 0.30 |
| ▸ | PPARA | Q07869 | 1/20 | 0.30 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.30 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25514033 | 0.85 | NTSR1 (0.36) | CA12CA1CA2CA9NTSR1 | |
| SCHEMBL26222089 | 0.84 | MCL1 (0.36) | CA12CA1CA2CA9NTSR1 | |
| SCHEMBL23775943 | 0.84 | HSD17B1 (0.33) | PRKDCHSD17B1HSD17B2 | |
| SCHEMBL24211415 | 0.82 | HSD17B1 (0.32) | HSD17B1HSD17B2 | |
| SCHEMBL19863144 | 0.79 | KDM4E (0.35) | CYP2C9CYP2C19HSD17B1HSD17B2 | |
| SCHEMBL19863137 | 0.79 | FLT3 (0.36) | CA12CA1CA2CA9CYP2C9 | |
| SCHEMBL19863141 | 0.79 | CA12 (0.46) | CA12CA1CA2CA9PRKDC | |
| SCHEMBL21453589 | 0.78 | CA12 (0.36) | CA12CA1CA2CA9 | |
| SCHEMBL15763553 | 0.78 | CA12 (0.46) | CA12CA1CA2CA9PRKDC | |
| SCHEMBL21453596 | 0.76 | FLT3 (0.36) | CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210257550-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2021-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210257550-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | CCNL2, CYBA, CYC1 | CA12 1854/4885CA1 2776/4885CA2 1573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.